Skip to main content Accessibility help

Policy brief on improving access to artemisinin-based combination therapies for malaria in the East African community

  • Harriet Nabudere (a1), Gabriel L. Upunda (a2) and Malick Juma (a3)

The World Health Organization (WHO) since June 1998 has advocated for the use of artemisinin-based combination therapies (ACTs) in countries where Plasmodium falciparum malaria is resistant to traditional antimalarial therapies such as chloroquine, sulfadoxine-pyrimethamine, and amodiaquine (19;22). In 2006, WHO released evidence-based guidelines for the treatment of malaria backed by findings from various scientific studies (21). During the period between 2002 and 2006, all the five East African states Tanzania, Kenya, Uganda, Rwanda, and Burundi changed their national antimalarial treatment policies to use ACTs as first-line treatments for uncomplicated falciparum malaria and commenced with deployment of the drugs in the state-managed health facilities (12–15). To scale up the use of ACTs in the East African region to combat malaria and speed up progress toward the sixth Millennium Development Goal, a combination of delivery, financial, and governance arrangements tailored to national or subnational contexts needs to be considered.

Hide All
1. Bennett, S. The role of community-based health insurance within the health care financing system: A framework for analysis. Health Policy Plan. 2004;19:147158.
2. Carrin, G, Waelkens, MP, Criel, B. Community-based health insurance in developing countries: A study of its contribution to the performance of health financing systems. Trop Med Int Health. 2005;10:799811.
3. Clinton Foundation. Distribution of artemisinin-based combination therapies through private sector channels: Lessons from four country case studies. New York: Clinton Foundation; 2008.
4. Ekman, B. Community-based health insurance in low-income countries: A systematic review of the evidence. Health Policy Plann. 2004;19:249270.
5. Fapohunda, BM, Beth, AP, Robert, A, et al. Home-based management of fever strategy in Uganda: A report of the 2003 survey. Arlington, VA: MOH, WHO and BASICS II; 2004.
6. Goodman, CA. An economic analysis of the retail market for fever and malaria treatment in rural Tanzania. Thesis submitted to the University of London for the Degree of Doctor of Philosophy. London: London School of Hygiene and Tropical Medicine, Health Policy Unit; 2004.
7. Grilli, R, Ramsay, C, Minozzi, S. Mass media interventions: Effects on health services utilisation. Cochrane Database Syst Rev. 2002;(1);1:CD000389.
8. Ikeoluwapo, OA, Browne, EN, Garshong, B, et al. Feasibility and acceptability of artemisinin-based combination therapy for the home management of malaria in four African sites. Malaria J. 2008;7:6.
9. Kutzin, J, Barnum, H. How health insurance affects the delivery of health care in developing countries. World Bank technical paper. Washington DC: World Bank; 1992.
10. Lagaarde, M, Palmer, N. Evidence from systematic reviews to inform decision making regarding financing mechanisms that improve access to health services for poor people. A policy brief prepared for the International Dialogue on Evidence-Informed Action to Achieve Health Goals in Developing Countries (IDEAHealth). Geneva: Alliance for Health Policy and Systems Research; 2006. (accessed February 28, 2008)
11. Lewin, SA, Babigumira, SM, Bosch-Capblanch, X, et al. Lay health workers in primary and community health care: A systematic review of trials. Geneva: Alliance for Health Policy and Systems Research; 2006. (accessed December 24, 2009)
12. Ministry of Health. Antimalarial treatment policy change to ACTs. Kampala, Uganda: Ministry of Health; 2005.
13. Ministry of Health. Management of uncomplicated malaria. A practical guide for health workers. 3rd ed. Kampala, Uganda: Ministry of Health Malaria Control Programme; 2005.
14. Ministry of Health. National guidelines for treatment. Diagnosis and prevention of malaria in Kenya. Nairobi, Kenya: Ministry of Health; 2006.
15. Ministry of Health. The guidelines for malaria diagnosis and treatment. Zanzibar: United Republic of Tanzania: Ministry of Health; 2007.
16. Ranson, MK. Reduction of catastrophic health care expenditures by a community-based health insurance scheme in Gujarat, India: Current experiences and challenges. Bull World Health Organ. 2002;80:613621.
17. Samarasekera, U. Drug subsidy could help Tanzania tackle malaria. Lancet. 2008;371:14031406.
18. Waters, H, Hatt, L, Peters, D. Working with the private sector for child health. Health Policy Plan. 2003;18:127137.
19. World Health Organization. Antimalarial drug combination therapy. Report of a WHO technical consultation. Geneva, Switzerland: World Health Organization; 2001.
20. World Health Organization. Burden of disease project. (accessed April 7, 2008).
21. World Health Organization. Guidelines for the treatment of malaria. Geneva, Switzerland: World Health Organization; 2006.
22. World Health Organization. The use of artemisinin and its derivatives as antimalarial drugs: A report of a joint CTD/DMP/TDR Informal Consultation. Geneva: World Health Organization; 1998. WHO/MAL/98.1086
23. World Health Organization. World malaria report 2008. Geneva: Global Malaria Programme; 2008. WHO/HTM/GMP/2008.
24. Yeboah-Antwi, K, Gyapong, JO, Asare, IK, et al. Impact of prepackaging antimalarial drugs on cost to patients and compliance with treatment. Bull World Health Organ. 2001;79:394399.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

International Journal of Technology Assessment in Health Care
  • ISSN: 0266-4623
  • EISSN: 1471-6348
  • URL: /core/journals/international-journal-of-technology-assessment-in-health-care
Please enter your name
Please enter a valid email address
Who would you like to send this to? *



Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed